Elsevier Announces New Edition of Infectious Diseases
Updated landmark text includes latest on H1N1 and many other timely topics
Philadelphia, 6 July, 2010 – Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the release of Infectious Diseases, 3rd Edition.
Presented in an engaging multi-media format that includes a robust set of interactive and online features, this completely revised landmark text remains unique among infectious disease resources; offering comprehensive, practical, highly visual guidance to effectively overcoming the latest clinical infectious disease challenges.
Edited by renowned experts Jonathan Cohen, William G. Powderly, and Steven M. Opal, Infectious Diseases provides brand-new information on new strains of the H1N1 and avian influenza viruses, SARS, nosocomial infections, HIV/AIDS, and many other timely topics. Seven new section editors, and an even more geographically diverse set of contributors, provide valuable global insights and clinical best practices on all forms of infectious disease.
Online features include access to the complete contents of this 2-volume set, regular content updates by the book’s editorial team, case studies with self-assessment questions, an interactive disease outbreak map, an antimicrobial pharmacokinetics mannequin, ID secret of the week, additional updates from The Lancet - Infectious Diseases, a downloadable image library, and more at Elsevier's Expert Consult web site.
# # #
Notes to Editors:
Infectious Diseases, 3rd Edition - Expert Consult Premium Edition - Enhanced Online Features and Print (ISBN: 978-0-7234-3503-7) is 2045 pages in length and contains approximately 1400 illustrations. It is edited by Jonathan Cohen, M Sc, FRCP, FRCPath, FRCPE, FMedSci, Professor of Infectious Diseases and Dean of the Medical School, Brighton & Sussex Medical School, Brighton, UK; Editor-in-Chief, International Journal of Infectious Diseases; William G. Powderly, MD, Head of School, UCD School of Medicine & Medical Science, Dublin, Ireland and Steven M. Opal, MD, Professor of Medicine, Division of Infectious Diseases, Brown University Medical School, Providence, RI, USA.
Infectious Diseases, 3rd Edition is available at http://www.us.elsevierhealth.com. Drs. Cohen, Powderly, and Opal may be reached for interviews by contacting Tom Reller at T.Reller@Elsevier.com. For review copies, please contact Helena Mutak at email@example.com or at 215.239.3509.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Tel: +1 212 462 1912